S46 Growth Hormone in Aging, Metabolisms, and Cancer: Are They All Linked?

Program: Symposia
Basic/Translational Session
Sunday, April 3, 2016: 8:15 AM-9:45 AM
Room 210 (BCEC)
Andrzej Bartke, PhD, Southern Illinois University School of Medicine, Springfield, IL

Nothing to Disclose: AB
8:15 AM
Stuart J Frank, MD, Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham/Veterans Affairs Medical Center at Birmingham, Birmingham, AL
Nothing to Disclose: SJF
8:45 AM
Darlene E Berryman, PhD, Edison Biotechnology Institute, Department of Biomedical Sciences, College of Osteopathic Medicine, School of Applied Health Sciences and Wellness, College of Health Sciences and Professions, Ohio University, Athens, OH
Nothing to Disclose: DEB
9:15 AM
Peter E Lobie, MD, PhD, Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
Nothing to Disclose: PEL
See more of: Symposia


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire